This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04526106
Brief Title: REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

First Submitted : August 7, 2020
First Submitted that Met QC Criteria : August 20, 2020
First Posted : August 25, 2020

Last Update Submitted that Met QC Criteria : March 1, 2024
Last Update Posted : March 5, 2024